MAYNE PHARMA GROUP LIMITED - Announcements

Market Cap $372.6M Add to my watchlist

Healthcare

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

RCE'S BREAKTHROUGH

Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition of its RECCE® 327 Gel (or R327G) as a topical treatment for burn wound infections, gaining a US$2 million grant from the US Department of Defense...

Announcements

Filter Results

All Price Sensitive Only

MYX	Change of Director's Interest Notice		14/12/15	430.33KB	Share
MYX	Ceasing to be a substantial holder		14/12/15	93.14KB	Share
MYX	Becoming a substantial holder		07/12/15	769.3KB	Share
MYX	Appendix 3B		04/12/15	376.89KB	Share
MYX	Results of Meeting		26/11/15	331.62KB	Share
MYX	2015 AGM CEO's Speech		26/11/15	218.92KB	Share
MYX	2015 AGM Chairman's Speech		26/11/15	209.59KB	Share
MYX	Appendix 3B		12/11/15	487.15KB	Share
MYX	Notice of Annual General Meeting/Proxy Form		23/10/15	554KB	Share
MYX	Appendix 4G		09/10/15	311.09KB	Share
MYX	Appendix 3B and lapse of employee options		22/09/15	620.8KB	Share
MYX	Change of Director's Interest Notices		07/09/15	268.26KB	Share
MYX	2015 Corporate Governance Statement		28/08/15	614.95KB	Share
MYX	2015 Full Year Results Investor Presentation		28/08/15	2.11MB	Share
MYX	2015 Full Year Results Media Release		28/08/15	237.22KB	Share
MYX	2015 Appendix 4E & Annual Report	PRICE SENSITIVE	28/08/15	4.5MB	Share
MYX	Mayne announces strategic investment in US facilities	PRICE SENSITIVE	28/08/15	252.01KB	Share
MYX	Appendix 3B		26/08/15	486.58KB	Share
MYX	Mayne Pharma launches Doryx 50mg Tablet		10/08/15	243.33KB	Share
MYX	Ceasing to be a substantial holder		07/08/15	32.03KB	Share
MYX	Appendix 3B		05/08/15	486.11KB	Share
MYX	Mayne Pharma appoints new senior management		05/08/15	244.43KB	Share
MYX	Mayne Pharma recipient of A$4m Government Grant	PRICE SENSITIVE	04/08/15	232.74KB	Share
MYX	Appendix 3B		04/08/15	485.8KB	Share
MYX	Appendix 3B and lapse of employee options		13/07/15	661.4KB	Share
MYX	Mayne Pharma successfully completes US$125m debt financing	PRICE SENSITIVE	25/06/15	209.94KB	Share
MYX	Appendix 3B		23/06/15	485.78KB	Share
MYX	Change of registered office address		22/06/15	210.61KB	Share
MYX	Appendix 3B		28/05/15	485.68KB	Share
MYX	Appendix 3B		18/05/15	485.28KB	Share
MYX	New equity investment in Hedgepath Pharmaceuticals	PRICE SENSITIVE	18/05/15	131.45KB	Share
MYX	Appendix 3B		06/05/15	374.62KB	Share
MYX	US Oxycodone franchise restructure and Doryx re-launch	PRICE SENSITIVE	04/05/15	244.02KB	Share
MYX	Appendix 3B		14/04/15	375.52KB	Share
MYX	Appendix 3B		27/03/15	486.07KB	Share
MYX	Appendix 3B		19/03/15	486.09KB	Share
MYX	Change of Director's Interest Notices (x3)		17/03/15	1MB	Share
MYX	Change in substantial holding		13/03/15	31.74KB	Share
MYX	Appendix 3B		11/03/15	487.59KB	Share
MYX	Retail Entitlement Offer Scale Back Policy		09/03/15	248.29KB	Share
MYX	Appendix 3B		05/03/15	364.65KB	Share
MYX	Change to option exercise price		02/03/15	291.33KB	Share
MYX	2015 Half Year Media Release		26/02/15	253.75KB	Share
MYX	Half Year Results and Accounts	PRICE SENSITIVE	26/02/15	912.55KB	Share
MYX	Pfizer withdraws US Tikosyn Litigation against Mayne Pharma	PRICE SENSITIVE	25/02/15	320.25KB	Share
MYX	Completion of Doryx acquisition		24/02/15	283.7KB	Share
MYX	Change of Director's Interest Notices		23/02/15	1.4MB	Share
MYX	Section 708A notice		20/02/15	253.41KB	Share
MYX	Appendix 3B		20/02/15	344.86KB	Share
MYX	Entitlement Offer - Notification to ineligible shareholders		18/02/15	338.69KB	Share
MYX	Retail Offer Booklet		18/02/15	5.68MB	Share
MYX	Completion institutional entitlement offer and placement	PRICE SENSITIVE	12/02/15	424.05KB	Share
MYX	Section 708A notice		10/02/15	253.4KB	Share
MYX	Appendix 3B		10/02/15	246.12KB	Share
MYX	Investor Presentation Acquisition of Doryx		10/02/15	1.45MB	Share
MYX	Mayne Pharma announces acquisition of Doryx	PRICE SENSITIVE	10/02/15	311.83KB	Share
MYX	Trading Halt	PRICE SENSITIVE	10/02/15	427.1KB	Share
MYX	Appendix 3B		06/02/15	300.9KB	Share
MYX	Appendix 3B		16/01/15	361.94KB	Share
MYX	Change of Director's Interest Notice		22/12/14	128.32KB	Share
MYX	Appendix 3B		22/12/14	535.79KB	Share
MYX	Change of Director's Interest Notice		18/12/14	129.92KB	Share
MYX	Change of Director's Interest Notice		05/12/14	128.07KB	Share
MYX	Appendix 3B		05/12/14	352.54KB	Share
MYX +PDL	Change in substantial holding from BTT		01/12/14	170.99KB	Share
MYX +WBC	Change in substantial holding from WBC		01/12/14	420.77KB	Share
MYX	Results of Meeting		27/11/14	402.62KB	Share
MYX	2014 AGM CEO's Speech		27/11/14	303.13KB	Share
MYX	2014 AGM Chairman's Speech		27/11/14	237.66KB	Share
MYX	Mayne Pharma announces US Paragraph IV Challenge	PRICE SENSITIVE	18/11/14	243.9KB	Share
MYX	Appendix 3B		30/10/14	297.66KB	Share
MYX	Notice of Annual General Meeting/Proxy Form		27/10/14	631.1KB	Share
MYX	Change of Director's Interest Notice		07/10/14	429.99KB	Share
MYX	Initial Director's Interest Notice		30/09/14	70.4KB	Share
MYX	Appendix 3B		10/09/14	296.81KB	Share
MYX +PDL	Change in substantial holding from BTT		05/09/14	223KB	Share
MYX +WBC	Change in substantial holding from WBC		05/09/14	472.16KB	Share
MYX	2014 Corporate Governance Statement		27/08/14	615.26KB	Share
MYX	2014 Full Year Results Investor Presentation		27/08/14	1.47MB	Share
MYX	2014 Full Year Results Media Release		27/08/14	253.41KB	Share
MYX	2014 Appendix 4E & Annual Report	PRICE SENSITIVE	27/08/14	2.8MB	Share
MYX	Mayne Pharma appoints new Board member		26/08/14	212.8KB	Share
MYX	Appendix 3B		25/08/14	299.9KB	Share
MYX	Mayne Pharma appoints Chief Scientific Officer		25/08/14	111.62KB	Share
MYX	Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals	PRICE SENSITIVE	25/06/14	133.3KB	Share
ACR +PRN EWC GXL MYX RRL SLR TGR TPI ZSP	S&P DJ Indices Announces June Quarterly Rebalance		06/06/14	38.73KB	Share
MYX	Wilson HTM Companies Conference Presentation		03/06/14	1.04MB	Share
MYX	Appendix 3B		12/05/14	337.44KB	Share
PDL +MYX	Becoming a substantial holder from BTT		10/04/14	168.79KB	Share
MYX +WBC	Initial Notice - WBC		10/04/14	414.44KB	Share
MYX	Appendix 3B		26/02/14	243.04KB	Share
MYX	2014 Half Year Investor Presentation		26/02/14	916.68KB	Share
MYX	2014 Half Year Media Release		26/02/14	244.82KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/14	929.67KB	Share
MYX	Appendix 3B		19/02/14	246.21KB	Share
MYX	Section 708A notice		19/02/14	217.03KB	Share
MYX	Completion of placement	PRICE SENSITIVE	13/02/14	108.63KB	Share
MYX	Investor Presentation Acquisition of LORCET & ESGIC		12/02/14	756.27KB	Share
MYX	Mayne Pharma announces acquisition of LORCET & ESGIC	PRICE SENSITIVE	12/02/14	249.77KB	Share
MYX	Trading Halt	PRICE SENSITIVE	12/02/14	373.4KB	Share

MYX Change of Director's Interest Notice
14/12/15		430.33KB	Share
MYX Ceasing to be a substantial holder
14/12/15		93.14KB	Share
MYX Becoming a substantial holder
07/12/15		769.3KB	Share
MYX Appendix 3B
04/12/15		376.89KB	Share
MYX Results of Meeting
26/11/15		331.62KB	Share
MYX 2015 AGM CEO's Speech
26/11/15		218.92KB	Share
MYX 2015 AGM Chairman's Speech
26/11/15		209.59KB	Share
MYX Appendix 3B
12/11/15		487.15KB	Share
MYX Notice of Annual General Meeting/Proxy Form
23/10/15		554KB	Share
MYX Appendix 4G
09/10/15		311.09KB	Share
MYX Appendix 3B and lapse of employee options
22/09/15		620.8KB	Share
MYX Change of Director's Interest Notices
07/09/15		268.26KB	Share
MYX 2015 Corporate Governance Statement
28/08/15		614.95KB	Share
MYX 2015 Full Year Results Investor Presentation
28/08/15		2.11MB	Share
MYX 2015 Full Year Results Media Release
28/08/15		237.22KB	Share
MYX 2015 Appendix 4E & Annual Report
28/08/15	PRICE SENSITIVE	4.5MB	Share
MYX Mayne announces strategic investment in US facilities
28/08/15	PRICE SENSITIVE	252.01KB	Share
MYX Appendix 3B
26/08/15		486.58KB	Share
MYX Mayne Pharma launches Doryx 50mg Tablet
10/08/15		243.33KB	Share
MYX Ceasing to be a substantial holder
07/08/15		32.03KB	Share
MYX Appendix 3B
05/08/15		486.11KB	Share
MYX Mayne Pharma appoints new senior management
05/08/15		244.43KB	Share
MYX Mayne Pharma recipient of A$4m Government Grant
04/08/15	PRICE SENSITIVE	232.74KB	Share
MYX Appendix 3B
04/08/15		485.8KB	Share
MYX Appendix 3B and lapse of employee options
13/07/15		661.4KB	Share
MYX Mayne Pharma successfully completes US$125m debt financing
25/06/15	PRICE SENSITIVE	209.94KB	Share
MYX Appendix 3B
23/06/15		485.78KB	Share
MYX Change of registered office address
22/06/15		210.61KB	Share
MYX Appendix 3B
28/05/15		485.68KB	Share
MYX Appendix 3B
18/05/15		485.28KB	Share
MYX New equity investment in Hedgepath Pharmaceuticals
18/05/15	PRICE SENSITIVE	131.45KB	Share
MYX Appendix 3B
06/05/15		374.62KB	Share
MYX US Oxycodone franchise restructure and Doryx re-launch
04/05/15	PRICE SENSITIVE	244.02KB	Share
MYX Appendix 3B
14/04/15		375.52KB	Share
MYX Appendix 3B
27/03/15		486.07KB	Share
MYX Appendix 3B
19/03/15		486.09KB	Share
MYX Change of Director's Interest Notices (x3)
17/03/15		1MB	Share
MYX Change in substantial holding
13/03/15		31.74KB	Share
MYX Appendix 3B
11/03/15		487.59KB	Share
MYX Retail Entitlement Offer Scale Back Policy
09/03/15		248.29KB	Share
MYX Appendix 3B
05/03/15		364.65KB	Share
MYX Change to option exercise price
02/03/15		291.33KB	Share
MYX 2015 Half Year Media Release
26/02/15		253.75KB	Share
MYX Half Year Results and Accounts
26/02/15	PRICE SENSITIVE	912.55KB	Share
MYX Pfizer withdraws US Tikosyn Litigation against Mayne Pharma
25/02/15	PRICE SENSITIVE	320.25KB	Share
MYX Completion of Doryx acquisition
24/02/15		283.7KB	Share
MYX Change of Director's Interest Notices
23/02/15		1.4MB	Share
MYX Section 708A notice
20/02/15		253.41KB	Share
MYX Appendix 3B
20/02/15		344.86KB	Share
MYX Entitlement Offer - Notification to ineligible shareholders
18/02/15		338.69KB	Share
MYX Retail Offer Booklet
18/02/15		5.68MB	Share
MYX Completion institutional entitlement offer and placement
12/02/15	PRICE SENSITIVE	424.05KB	Share
MYX Section 708A notice
10/02/15		253.4KB	Share
MYX Appendix 3B
10/02/15		246.12KB	Share
MYX Investor Presentation Acquisition of Doryx
10/02/15		1.45MB	Share
MYX Mayne Pharma announces acquisition of Doryx
10/02/15	PRICE SENSITIVE	311.83KB	Share
MYX Trading Halt
10/02/15	PRICE SENSITIVE	427.1KB	Share
MYX Appendix 3B
06/02/15		300.9KB	Share
MYX Appendix 3B
16/01/15		361.94KB	Share
MYX Change of Director's Interest Notice
22/12/14		128.32KB	Share
MYX Appendix 3B
22/12/14		535.79KB	Share
MYX Change of Director's Interest Notice
18/12/14		129.92KB	Share
MYX Change of Director's Interest Notice
05/12/14		128.07KB	Share
MYX Appendix 3B
05/12/14		352.54KB	Share
MYX +PDL Change in substantial holding from BTT
01/12/14		170.99KB	Share
MYX +WBC Change in substantial holding from WBC
01/12/14		420.77KB	Share
MYX Results of Meeting
27/11/14		402.62KB	Share
MYX 2014 AGM CEO's Speech
27/11/14		303.13KB	Share
MYX 2014 AGM Chairman's Speech
27/11/14		237.66KB	Share
MYX Mayne Pharma announces US Paragraph IV Challenge
18/11/14	PRICE SENSITIVE	243.9KB	Share
MYX Appendix 3B
30/10/14		297.66KB	Share
MYX Notice of Annual General Meeting/Proxy Form
27/10/14		631.1KB	Share
MYX Change of Director's Interest Notice
07/10/14		429.99KB	Share
MYX Initial Director's Interest Notice
30/09/14		70.4KB	Share
MYX Appendix 3B
10/09/14		296.81KB	Share
MYX +PDL Change in substantial holding from BTT
05/09/14		223KB	Share
MYX +WBC Change in substantial holding from WBC
05/09/14		472.16KB	Share
MYX 2014 Corporate Governance Statement
27/08/14		615.26KB	Share
MYX 2014 Full Year Results Investor Presentation
27/08/14		1.47MB	Share
MYX 2014 Full Year Results Media Release
27/08/14		253.41KB	Share
MYX 2014 Appendix 4E & Annual Report
27/08/14	PRICE SENSITIVE	2.8MB	Share
MYX Mayne Pharma appoints new Board member
26/08/14		212.8KB	Share
MYX Appendix 3B
25/08/14		299.9KB	Share
MYX Mayne Pharma appoints Chief Scientific Officer
25/08/14		111.62KB	Share
MYX Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals
25/06/14	PRICE SENSITIVE	133.3KB	Share
ACR +PRN EWC GXL MYX RRL SLR TGR TPI ZSPS&P DJ Indices Announces June Quarterly Rebalance
06/06/14		38.73KB	Share
MYXWilson HTM Companies Conference Presentation
03/06/14		1.04MB	Share
MYXAppendix 3B
12/05/14		337.44KB	Share
PDL +MYXBecoming a substantial holder from BTT
10/04/14		168.79KB	Share
MYX +WBCInitial Notice - WBC
10/04/14		414.44KB	Share
MYXAppendix 3B
26/02/14		243.04KB	Share
MYX2014 Half Year Investor Presentation
26/02/14		916.68KB	Share
MYX2014 Half Year Media Release
26/02/14		244.82KB	Share
MYXHalf Yearly Report and Accounts
26/02/14	PRICE SENSITIVE	929.67KB	Share
MYXAppendix 3B
19/02/14		246.21KB	Share
MYXSection 708A notice
19/02/14		217.03KB	Share
MYXCompletion of placement
13/02/14	PRICE SENSITIVE	108.63KB	Share
MYXInvestor Presentation Acquisition of LORCET & ESGIC
12/02/14		756.27KB	Share
MYXMayne Pharma announces acquisition of LORCET & ESGIC
12/02/14	PRICE SENSITIVE	249.77KB	Share
MYXTrading Halt
12/02/14	PRICE SENSITIVE	373.4KB	Share

REFRESH

First 4 5 6 7 8

(20min delay)
Last $4.38		Change 0.440(11.2%)		Mkt cap ! $372.6M

Open	High	Low	Value	Volume
$4.40	$4.79	$4.18	$2.649M	590.1K

Buyers (Bids)

No.	Vol.	Price($)
1	1271	$4.35

Sellers (Offers)

Price($)	Vol.	No.
$4.44	1271	1

View Market Depth

No.	Vol.	Price($)
1	2000	4.200
1	3000	4.110
1	1000	4.080
1	180	4.060
8	9994	4.050

Price($)	Vol.	No.
4.450	6200	1
4.500	450	1
4.700	367	2
4.730	1805	1
4.740	4111	2

Last trade - 16.10pm 23/08/2024 (20 minute delay)


Last $4.38		Change 0.440 ( 11.0 %)
Open	High	Low	Volume
$4.42	$4.79	$4.21	26856
Last updated 15.59pm 23/08/2024 ?

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories